vs
Side-by-side financial comparison of Invesco Mortgage Capital Inc. (IVR) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.
Invesco Mortgage Capital Inc. is the larger business by last-quarter revenue ($21.3M vs $13.3M, roughly 1.6× OCULAR THERAPEUTIX, INC). Invesco Mortgage Capital Inc. runs the higher net margin — 242.2% vs -488.0%, a 730.2% gap on every dollar of revenue. On growth, Invesco Mortgage Capital Inc. posted the faster year-over-year revenue change (55.4% vs -22.4%). Over the past eight quarters, Invesco Mortgage Capital Inc.'s revenue compounded faster (74.2% CAGR vs -5.3%).
Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.
Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.
IVR vs OCUL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.3M | $13.3M |
| Net Profit | $51.5M | $-64.7M |
| Gross Margin | — | 88.0% |
| Operating Margin | — | -526.5% |
| Net Margin | 242.2% | -488.0% |
| Revenue YoY | 55.4% | -22.4% |
| Net Profit YoY | 1368.7% | -33.6% |
| EPS (diluted) | $0.72 | $-0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.3M | $13.3M | ||
| Q3 25 | $17.6M | $14.5M | ||
| Q2 25 | $17.7M | $13.5M | ||
| Q1 25 | $18.8M | $10.7M | ||
| Q4 24 | $13.7M | $17.1M | ||
| Q3 24 | $7.5M | $15.4M | ||
| Q2 24 | $8.6M | $16.4M | ||
| Q1 24 | $7.0M | $14.8M |
| Q4 25 | $51.5M | $-64.7M | ||
| Q3 25 | $53.5M | $-69.4M | ||
| Q2 25 | $-23.3M | $-67.8M | ||
| Q1 25 | $19.6M | $-64.1M | ||
| Q4 24 | $3.5M | $-48.4M | ||
| Q3 24 | $40.7M | $-36.5M | ||
| Q2 24 | $-13.5M | $-43.8M | ||
| Q1 24 | $29.1M | $-64.8M |
| Q4 25 | — | 88.0% | ||
| Q3 25 | — | 87.8% | ||
| Q2 25 | — | 85.6% | ||
| Q1 25 | — | 88.2% | ||
| Q4 24 | — | 92.8% | ||
| Q3 24 | — | 89.9% | ||
| Q2 24 | — | 90.8% | ||
| Q1 24 | — | 91.0% |
| Q4 25 | — | -526.5% | ||
| Q3 25 | — | -472.3% | ||
| Q2 25 | — | -502.6% | ||
| Q1 25 | — | -597.5% | ||
| Q4 24 | — | -296.1% | ||
| Q3 24 | — | -298.2% | ||
| Q2 24 | — | -265.1% | ||
| Q1 24 | — | -214.0% |
| Q4 25 | 242.2% | -488.0% | ||
| Q3 25 | 303.6% | -477.3% | ||
| Q2 25 | -131.6% | -503.9% | ||
| Q1 25 | 104.4% | -598.7% | ||
| Q4 24 | 25.6% | -283.3% | ||
| Q3 24 | 542.2% | -236.6% | ||
| Q2 24 | -155.9% | -266.3% | ||
| Q1 24 | 415.9% | -438.9% |
| Q4 25 | $0.72 | $-0.27 | ||
| Q3 25 | $0.74 | $-0.38 | ||
| Q2 25 | $-0.40 | $-0.39 | ||
| Q1 25 | $0.26 | $-0.38 | ||
| Q4 24 | $-0.09 | $-0.25 | ||
| Q3 24 | $0.63 | $-0.22 | ||
| Q2 24 | $-0.38 | $-0.26 | ||
| Q1 24 | $0.49 | $-0.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $56.0M | $737.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $797.5M | $654.3M |
| Total Assets | $6.5B | $808.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $56.0M | $737.1M | ||
| Q3 25 | $58.5M | $344.8M | ||
| Q2 25 | $59.4M | $391.1M | ||
| Q1 25 | $42.9M | $349.7M | ||
| Q4 24 | $73.4M | $392.1M | ||
| Q3 24 | $48.3M | $427.2M | ||
| Q2 24 | $58.8M | $459.7M | ||
| Q1 24 | $59.9M | $482.9M |
| Q4 25 | $797.5M | $654.3M | ||
| Q3 25 | $769.6M | $258.2M | ||
| Q2 25 | $709.4M | $305.9M | ||
| Q1 25 | $759.2M | $265.9M | ||
| Q4 24 | $730.7M | $315.3M | ||
| Q3 24 | $857.0M | $352.0M | ||
| Q2 24 | $759.2M | $377.7M | ||
| Q1 24 | $785.6M | $408.0M |
| Q4 25 | $6.5B | $808.1M | ||
| Q3 25 | $6.0B | $410.9M | ||
| Q2 25 | $5.4B | $451.3M | ||
| Q1 25 | $6.2B | $405.9M | ||
| Q4 24 | $5.7B | $457.9M | ||
| Q3 24 | $6.1B | $490.4M | ||
| Q2 24 | $5.1B | $517.1M | ||
| Q1 24 | $5.2B | $538.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $157.1M | $-54.2M |
| Free Cash FlowOCF − Capex | — | $-57.1M |
| FCF MarginFCF / Revenue | — | -430.9% |
| Capex IntensityCapex / Revenue | — | 21.4% |
| Cash ConversionOCF / Net Profit | 3.05× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-216.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $157.1M | $-54.2M | ||
| Q3 25 | $37.3M | $-50.7M | ||
| Q2 25 | $40.6M | $-55.2M | ||
| Q1 25 | $19.3M | $-44.7M | ||
| Q4 24 | $183.2M | $-39.4M | ||
| Q3 24 | $30.8M | $-36.6M | ||
| Q2 24 | $33.0M | $-24.8M | ||
| Q1 24 | $57.5M | $-33.9M |
| Q4 25 | — | $-57.1M | ||
| Q3 25 | — | $-56.7M | ||
| Q2 25 | — | $-56.5M | ||
| Q1 25 | — | $-46.6M | ||
| Q4 24 | — | $-39.6M | ||
| Q3 24 | — | $-36.6M | ||
| Q2 24 | — | $-25.5M | ||
| Q1 24 | — | $-34.1M |
| Q4 25 | — | -430.9% | ||
| Q3 25 | — | -390.0% | ||
| Q2 25 | — | -419.7% | ||
| Q1 25 | — | -435.6% | ||
| Q4 24 | — | -232.0% | ||
| Q3 24 | — | -237.6% | ||
| Q2 24 | — | -155.4% | ||
| Q1 24 | — | -231.1% |
| Q4 25 | — | 21.4% | ||
| Q3 25 | — | 41.2% | ||
| Q2 25 | — | 9.3% | ||
| Q1 25 | — | 18.1% | ||
| Q4 24 | — | 1.2% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | 1.7% |
| Q4 25 | 3.05× | — | ||
| Q3 25 | 0.70× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 52.24× | — | ||
| Q3 24 | 0.76× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.97× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
